RARA and cancer: As for possible associations between RAR splicing variants and tumor cell phenotype, in accordance with the cell-line data, the content of RARa3 is generally higher in Luminal, relative to TN cancers and HER2+ tumors with no co-amplification of the ERBB2 and RARA loci (Fig7A).